Multivalent feedback regulation of HMG CoA reductase, a control mechanism coordinating isoprenoid synthesis and cell growth.

The availability of compactin (ML-236B), a potent competitive inhibitor of 3-hydroxy-3-methylglutaryl Coenzyme A reductase, has permitted the demonstration of a hitherto unsuspected aspect of mevalonate metabolism and isoprenoid synthesis in cultured mammalian cells. 3-Hydroxy-3-methylglutaryl Coenzyme A reductase, the enzyme that synthesizes mevalonate, appears to be regulated through a multivalent feedback mechanism. Full suppression of the reductase requires the presence of at least two regulators: 1) cholesterol, which is normally derived exogenously from plasma low density lipoprotein (LDL), and 2) a nonsterol product, which is normally synthesized endogenously from mevalonate. Evidence indicates that both of these regulators of the reductase may be essential for the growth of mammalian cells in culture. The multivalent feedback regulation of 3-hydroxy-3-methylglutaryl Coenzyme A reductase, together with secondary regulatory changes in other enzymes of the sterol synthetic pathway, coordinates the branched pathway of mevalonate metabolism so as to assure a constant supply of cholesterol and nonsterol products. These new findings have important implications for the understanding of isoprenoid metabolism and its relation to cell growth.

[1]  R. Ross,et al.  Relation of cholesterol and mevalonic acid to the cell cycle in smooth muscle and swiss 3T3 cells stimulated to divide by platelet-derived growth factor. , 1980, The Journal of biological chemistry.

[2]  Endo Akira,et al.  Effects of ML-236B on cholesterol metabolism in mice and rats: Lack of hypocholesterolemic activity in normal animals , 1979 .

[3]  J. Watson,et al.  Regulation of cholesterol synthesis in primary rat hepatocyte culture cells. Possible regulatory site at sterol demethylation. , 1979, The Journal of biological chemistry.

[4]  M. Brown,et al.  Squalene synthetase activity in human fibroblasts: regulation via the low density lipoprotein receptor. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[5]  M. Wiley,et al.  Essential role for mevalonate synthesis in DNA replication. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[6]  M. James,et al.  Inter-relationships between dolichol and sterol synthesis in mammalian cell cultures. , 1979, The Journal of biological chemistry.

[7]  R. Gonzalez,et al.  Two major regulatory steps in cholesterol synthesis by human renal cancer cells. , 1979, Archives of biochemistry and biophysics.

[8]  M. Brown,et al.  Receptor-mediated endocytosis: insights from the lipoprotein receptor system. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Brown,et al.  Active and inactive forms of 3-hydroxy-3-methylglutaryl coenzyme A reductase in the liver of the rat. Comparison with the rate of cholesterol synthesis in different physiological states. , 1979, The Journal of biological chemistry.

[10]  M. Brown,et al.  Inhibition of cholesterol synthesis with compactin renders growth of cultured cells dependent on the low density lipoprotein receptor. , 1979, The Journal of biological chemistry.

[11]  M. Brown,et al.  Synthesis of ubiquinone and cholesterol in human fibroblasts: regulation of a branched pathway. , 1979, Archives of biochemistry and biophysics.

[12]  Y. Tsujita,et al.  Effects of ML-236B on cholesterol metabolism in mice and rats: lack of hypocholesterolemic activity in normal animals. , 1979, Biochimica et biophysica acta.

[13]  T. Ingebritsen,et al.  Reversible modulation of liver hydroxymethylglutaryl CoA reductase. , 1978, Life sciences.

[14]  M. Krieger,et al.  Receptor-mediated uptake of low density lipoprotein reconstituted with 25-hydroxycholesteryl oleate suppresses 3-hydroxy-3-methylglutaryl-coenzyme A reductase and inhibits growth of human fibroblasts. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[15]  A. Adamany,et al.  Impairment of dolichyl saccharide synthesis and dolichol-mediated glycoprotein assembly in the aortic smooth muscle cell in culture by inhibitors of cholesterol biosynthesis. , 1978, The Journal of biological chemistry.

[16]  I. Kaneko,et al.  Inhibitory effects on lipid metabolism in cultured cells of ML-236B, a potent inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme-A reductase. , 1978, European journal of biochemistry.

[17]  M. Brown,et al.  Induction of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts incubated with compactin (ML-236B), a competitive inhibitor of the reductase. , 1978, The Journal of biological chemistry.

[18]  J. Nordstrom,et al.  Interconversion of active and inactive forms of rat liver hydroxymethylglutaryl-CoA reductase. , 1977, The Journal of biological chemistry.

[19]  M. Brown,et al.  Regulation of cholesterol synthesis in rat adrenal gland through coordinate control of 3-hydroxy-3-methylglutaryl coenzyme A synthase and reductase activities. , 1977, Proceedings of the National Academy of Sciences of the United States of America.

[20]  P. Edwards,et al.  Control of 3-hydroxy-3-methylglutaryl coenzyme A reductase by endogenously synthesized sterols in vitro and in vivo. , 1977, The Journal of biological chemistry.

[21]  M. Brown,et al.  The low-density lipoprotein pathway and its relation to atherosclerosis. , 1977, Annual review of biochemistry.

[22]  B. Ed,et al.  Biochemistry of Polyisoprenoid Biosynthesis , 1976 .

[23]  J. Porter,et al.  Biochemistry of polyisoprenoid biosynthesis. , 1976, Annual review of biochemistry.

[24]  A. Brown,et al.  Crystal and molecular structure of compactin, a new antifungal metabolite from Penicillium brevicompactum. , 1976, Journal of the Chemical Society. Perkin transactions 1.

[25]  J. Goldstein,et al.  Regulation of the activity of the low density lipoprotein receptor in human fibroblasts , 1975, Cell.

[26]  A. Mittelman,et al.  CYTOKININS AS CHEMOTHERAPEUTIC AGENTS * , 1975, Annals of the New York Academy of Sciences.

[27]  M. Brown,et al.  Cholesterol ester formation in cultured human fibroblasts. Stimulation by oxygenated sterols. , 1975, The Journal of biological chemistry.

[28]  M. Lane,et al.  Molecular and catalytic properties of mitochondrial (ketogenic) 3-hydroxy-3-methylglutaryl coenzyme A synthase of liver. , 1975, The Journal of biological chemistry.

[29]  M. Brown,et al.  Inactivation of 3-hydroxy-3-methylglutaryl coenzyme A reductase in vitro. An adenine nucleotide-dependent reaction catalyzed by a factor in human fibroblasts. , 1975, The Journal of biological chemistry.

[30]  A. Kandutsch,et al.  Regulation of sterol synthesis in cultured cells by oxygenated derivatives of cholesterol , 1975, Journal of cellular physiology.

[31]  M. Brown,et al.  Suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and inhibition of growth of human fibroblasts by 7-ketocholesterol. , 1974, The Journal of biological chemistry.

[32]  A. Kandutsch,et al.  Inhibition of cell growth by oxygenated derivatives of cholesterol , 1974, Nature.

[33]  M. Brown,et al.  Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. , 1974, The Journal of biological chemistry.

[34]  J. Edmond,et al.  Transfer of carbon atoms from mevalonate to n-fatty acids. , 1974, The Journal of biological chemistry.

[35]  P. Raskin,et al.  Mevalonate metabolism by renal tissue in vitro. , 1974, Journal of lipid research.

[36]  M. Brown,et al.  Regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity in human fibroblasts by lipoproteins. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[37]  A. Qureshi,et al.  The effects of fasting, refeeding, and time of day on the levels of enzymes effecting the conversion of -hydroxy- -methylglutaryl-coenzyme A to squalene. , 1972, The Journal of biological chemistry.

[38]  F. Hemming,et al.  The characterization and stereochemistry of biosynthesis of dolichols in rat liver. , 1970, The Biochemical journal.

[39]  E. Stadtman.  8 Mechanisms of Enzyme Regulation in Metabolism , 1970 .

[40]  R. H. Hall.  N6-(δ2-Isopentenyl)adenosine: Chemical Reactions, Biosynthesis, Metabolism, and Significance to the Structure and Function of †RNA , 1970 .

[41]  R. Olson,et al.  The effect of exogenous cholesterol on the synthesis in vivo of cholesterol, ubiquinone, and squalene in rat liver. , 1967, Biochemical and biophysical research communications.

[42]  R. Gould,et al.  Sites of control of hepatic cholesterol biosynthesis. , 1966, Journal of lipid research.

[43]  R. Olson.  Biosynthesis of ubiquinones in animals. , 1966, Vitamins and hormones.

[44]  R. Ryhage,et al.  Studies on the biosynthesis of cholesterol. XV. Mechanism of squalene biosynthesis from farnesyl pyrophosphate and from mevalonate. , 1961, The Journal of biological chemistry.

[45]  M. Siperstein,et al.  Studies on the site of the feedback control of cholesterol synthesis. , 1960, The Journal of clinical investigation.

[46]  K. Bloch.  Biological synthesis of cholesterol. , 1965, Harvey lectures.